Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

New Therapeutic Approach in Upper Limb Lymphedema Secondary to Breast Cancer: Activity-oriented Proprioceptive Antiedema Therapy (TAPA). A Randomized Controlled Therapy

NCT03762044 is registered in ClinicalTrials.gov with Hospital Universitario Reina Sofia de Cordoba as lead sponsor.

NCT NCT03762044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03762044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
New Therapeutic Approach in Upper Limb Lymphedema Secondary to Breast Cancer: Activity-oriented Proprioceptive Antiedema Therapy (TAPA). A Randomized Controlled Therapy
Lead sponsor
Hospital Universitario Reina Sofia de Cordoba
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2019
Completion date
February 1, 2022
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer lymphedema, post-mastectomy secondary lymphedema